XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)
$6.16 -0.16 (-2.5316%)
Analysed XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) News Sources
Does Record Q4 Results, Robust 2026 Guidance and Recorlev Patent Suit Change The Bull Case For Xeris (XERS)?
13-04-2026
yahoo.com
Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
23-04-2026
yahoo.com
Xeris Biopharma Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07-05-2026
yahoo.com
Xeris (XERS) Q1 2026 Earnings Call Transcript
07-05-2026
fool.com
Xeris Biopharma Holdings (XERS) Is Up 8.2% After Swing to Q1 Profitability - What's Changed
08-05-2026
yahoo.com
Xeris Biopharma Holdings, Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
Xeris Biopharma Q1 Earnings Call Highlights
09-05-2026
marketbeat.com
Results: Xeris Biopharma Holdings, Inc. Confounded Analyst Expectations With A Surprise Profit
09-05-2026
yahoo.com
Shareholders Will Be Pleased With The Quality of Xeris Biopharma Holdings' (NASDAQ:XERS) Earnings
15-05-2026
yahoo.com
What is the current price of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)?
The current price of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) is $6.16.
XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) absolute price change since previous trading day?
The absolute price change of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) since the previous trading day is $-0.16.
XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) percentage price change since previous trading day?
The percentage price change of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) since the previous trading day is -2.5316%.
What is the most recent average sentiment score for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)?
The most recent average sentiment score for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)?
The most recent sentiment for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) is .
SEC-8K** Filing Available For XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.